Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Erez Chimovits currently holds 17,096 shares of LogicBio Therapeutics, Inc. (LOGC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erez Chimovits has been a net buyer of LOGC stock. They have purchased $16.0M and sold $0 worth of shares.
Erez Chimovits's most recent insider trade was on Oct 15, 2024, when they sold 789,833 shares at $0.00 per share.
Erez Chimovits serves as Executive at LogicBio Therapeutics, Inc. (LOGC). They have executed 24 insider transactions totaling $16.0M over their tenure at the company.
Erez Chimovits holds the position of Executive at LogicBio Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Erez Chimovits has shown a buying trading pattern, with $16.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Erez Chimovits was on Feb 12, 2021, when they purchased $5.5M worth of ACET shares. This transaction involved 420,299 shares at $13.00 per share.
Erez Chimovits currently owns 17,096 shares of LogicBio Therapeutics, Inc. (LOGC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Erez Chimovits's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Erez Chimovits has 24 Form 4 filings on record as an insider at LogicBio Therapeutics, Inc..
Set alerts for Erez Chimovits and 40,000+ other insiders.